S

Sanofi

Global pharma company; vaccines and R&D

Team Lead Business Analytics

Full-TimeUpdated on 10/23/2026Deadline 11/15/26
No salary listed
Expert
Master's, MBA, PhD
Hyderabad, Telangana, India
In PersonHyderabad-based; travel may be required as business needs arise.
Data & AnalyticsBusiness Intelligence

About the job

Requirements
  • 12+ years of relevant experience in pharmaceutical commercial operations.
  • 12+ years of experience in pharmaceutical product commercial analytics and/or forecasting.
  • In-depth knowledge of databases such as IQVIA, APLD, engagement data, and execution data.
  • Strong ability to manage a multi-layered team of 50 people.
  • Demonstrated leadership and management in driving innovation and automation using advanced statistical and analytical techniques.
  • Experience recruiting, selecting, orienting, and training associates, and resolving conflicts or complaints from stakeholders and associates.
  • Experience supervising project activities and ensuring projects are properly provisioned and staffed.
  • Strong learning agility and ability to manage ambiguous environments and adapt to changing business needs.
  • Strong interpersonal, communication, and presentation skills.
  • Ability to work collaboratively, think strategically, influence and negotiate, and operate effectively in an international matrix environment across time zones.
  • Proficiency in stakeholder management, project management, and people management.
  • Fluency with the R programming language, visualization, and statistical analysis.
  • Knowledge of project management tools.
  • Proficiency in SQL, SAS, Python, R, or VBA.
  • Experience with analytical platforms such as Databricks, Jupyter Notebook, and SQL developers.
  • Proficiency with pharmaceutical and commercial data sources and CRM systems such as IQVIA, Symphony, Komodo, Veeva, and Salesforce.
  • Experience with analytical tools such as Power BI, Qlik Sense, Tableau, Smartsheet, and Alteryx.
  • Expert knowledge of Excel and proficiency in VBA.
  • Experience developing and managing dashboards.
  • Ability to prioritize and handle multiple projects simultaneously.
  • Problem-solving and strategic-thinking skills, with a focus on high-quality data output and quality assurance.
  • Ability to synthesize complex information into clear, actionable insights and work effectively across stakeholder levels and diverse functions.
  • Solid understanding of pharmaceutical development, manufacturing, supply chain, and marketing functions.
  • An advanced degree in areas such as Management, Statistics, Decision Sciences, Engineering, Life Sciences, or Business Analytics, or a related field; examples include a PhD, MBA, or Master's degree.
  • Excellent knowledge of English.
Responsibilities
  • Maintain effective relationships with end stakeholders in allocated GBUs and develop education and communication content as required.
  • Lead and develop hub teams and ensure they leverage new technologies.
  • Initiate the contracting process and related documentation within defined timelines.
  • Collaborate with global stakeholders on project planning, timelines, and budgets.
  • Act as a strategic thought partner to commercial and analytics operations across GBUs.
  • Develop and maintain expertise in key industry trends and developments.
  • Contribute to strategic deliverables and ensure delivery according to plan.
  • Identify innovation opportunities and implement them with external and internal partners.
  • Refresh existing reports and identify improvement opportunities in reporting and business intelligence tools, structure, and functionality as new insights become available.
  • Create dashboards that synthesize and visualize key information to support business decisions.
  • Develop deal-tracking analytics and reporting capabilities.
  • Collaborate with Digital to enhance access to data from various sources and develop tools, technology, and processes to improve quality and productivity.
  • Standardize and automate offerings, models, and processes to improve the efficiency of repeated or routine work.
  • Rationalize reports to reduce data redundancy and free capacity for new initiatives and projects.
  • Synthesize data and insights by gathering input from Market Research, Brand Analytics, Marketing, Finance, Market Access, Medical, and other functions.
  • Provide quarterly utilization metrics for reports using Power BI usage metrics or other methods for reports outside the business intelligence framework.
  • Assist in developing and maintaining KPI reports for field and commercial teams, covering Marketing and related functions, and access information through various tools and sources.
  • Develop a deep understanding of internal customers' data and analytical needs, focusing on the customer-facing model.
  • Monitor therapeutic-area research, clinical development, and competitor activity; summarize and present findings through appropriate communication channels.
  • Apply and share deeper technical knowledge across the function, including key datasets and modeling capabilities.
  • Lead teams of advanced business analytics experts and other specialists as needed.
  • Partner with internal cross-business-unit client teams across regions to provide quantitative strategy consulting and solutions for marketing and sales issues.
  • Evaluate promotion and marketing program effectiveness using secondary data sources, marketing mix or promotion response models, return-on-investment analysis, and field-force or multichannel modeling.
  • Coach and develop team leads and similar roles in team handling, project management, and methods.
  • Mentor the team on day-to-day work and exceptional cases or situations.
  • Monitor work progress and resolve issues and queries.
  • Plan resourcing and backups to ensure business continuity.
  • Share best practices and facilitate change and operational excellence.
  • Coordinate project resourcing, quality, timeliness, efficiency, and technical standards for medical/field-writing group deliverables, including scientific documents and clinical/medical reports.
  • Enhance quality by ensuring medical/field-writing outputs meet high scientific standards.
  • Ensure compliance procedures and internal operational risk controls are followed in accordance with applicable standards.
  • Refresh reports on weekly, monthly, quarterly, or annual cycles and perform quality-control checks for each refresh.
  • Use current tools, technologies, and methodologies and partner with internal teams on regular and ad hoc business analytics work, including system builds, maintenance, and enhancements.
  • Gather requirements, analyze data, and generate insights and reports for the GBU through cross-functional collaboration.
  • Work with stakeholder teams to prioritize work and deliver time-sensitive requests.
  • Present and defend intelligence, methodology, content, and conclusions to global leadership clearly and concisely.
  • Coordinate project resourcing, quality, timeliness, efficiency, and deliverable standards for commercial operations teams.
  • Improve quality by ensuring team outputs meet defined or agreed quality parameters.
  • Ensure compliance procedures and internal operational risk controls meet applicable regulatory standards.
  • Lead and implement operational excellence projects aligned with senior leadership direction, using appropriate process-improvement tools.
  • Create and develop tools, technology, and processes to improve quality and productivity.
  • Maintain effective stakeholder relationships to meet agreed deliverables.
  • Partner with Global Analytics Center of Excellence representatives and remain accountable for Global Service Hub work.
  • Develop marketing concepts, points of view, problem-solving tools, frameworks, and approaches with Global Analytics Center of Excellence and Regional Analytics colleagues.
  • Support global stakeholders with process improvements, risk mitigation plans, and new initiatives.
  • Collaborate with stakeholders to understand requirements and propose solutions aligned with expectations.
  • Establish regular stakeholder governance, seek feedback, and take appropriate action to ensure stakeholder satisfaction.

About the company

Sanofi is a global pharmaceutical and biotechnology company that develops, manufactures, and sells prescription medicines, over-the-counter products, and vaccines. Its products span immunology, oncology, rare diseases, and vaccines, addressing unmet medical needs through a strong focus on research and development. Sanofi's core product model relies on large-scale R&D, strategic partnerships, and licensing to bring new therapies to markets, with revenue generated from product sales and collaborations. The company differentiates itself by leveraging its global reach, diverse portfolio, and emphasis on patient-centric solutions, safety, and quality to navigate regulatory environments in developed and emerging markets. The company’s goal is to improve health outcomes and quality of life for people worldwide by delivering innovative treatments and vaccines that meet unmet medical needs.

Company Size

10,001+

Company Stage

IPO

Headquarters

Paris, France

Founded

1973

Get referred to Sanofi

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • July 10, 2026 FDA approval of Sarclisa Escena created the first on-body cancer injector.
  • June 13, 2026 FDA accelerated approval expanded Tzield into recently diagnosed stage 3 T1D.
  • Q2 2026 sales grew 17.8% at CER, with Dupixent and Beyfortus leading.

What critics are saying

  • Texas sued Sanofi on February 19, 2026 over provider bribery and Medicaid fraud.
  • Sanofi sued Pfizer and Moderna on July 15, 2026, extending costly mRNA patent warfare.
  • Dupixent concentration makes 2030s patent loss an existential revenue shock.

What makes Sanofi unique

  • Dupixent reached €5.2 billion quarterly sales in Q2 2026 across nine indications.
  • October 1, 2026, Sanofi and Regeneron added four long-acting antibodies to their Alliance.
  • Sanofi's 61-project pipeline spans immunology, rare diseases, vaccines, neurology, and oncology.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Professional Development Budget
  • Parental Leave

Company News

Associated Press
Oct 19th, 2026
Enable Injections wins first Japan approval for enFuse on-body injector via Sanofi's CirCLIQ

Enable Injections has won its first commercial product approval in Japan. The country's Ministry of Health, Labour and Welfare approved the company's enFuse On-Body Delivery System through Sanofi's CirCLIQ Injector. The device delivers a subcutaneous form of Sarclisa (isatuximab) with the push of a button, for treating multiple myeloma. It is the first anticancer treatment given through an on-body injector in Japan. The approval follows recent clearances in the US and Europe. Japan approved Sarclisa SC in June 2026, backed by the IRAKLIA phase 3 study, which showed the subcutaneous form was non-inferior to intravenous delivery. "We're proud to partner with Sanofi to bring our enFuse technology to patients in Japan," said Michael D. Hooven, chairman and chief executive officer of Enable.

Yahoo Finance
Oct 1st, 2026
Sanofi, Regeneron expand alliance in up to $8B deal for immunology drugs

France's Sanofi and US-based Regeneron Pharmaceuticals will expand their 20-year partnership to jointly develop and market immunology medicines in a deal worth up to $8 billion. Regeneron will receive $1 billion upfront, with potential additional payments of up to $7 billion tied to development, regulatory, and commercial targets. The collaboration will add four next-generation immunology drug candidates invented by Regeneron, with one currently in early-stage trials for eczema. The companies will equally share development costs and future profits from new drugs, whilst their existing profit-sharing agreement for top-selling medicine Dupixent remains unchanged. The deal settles prior litigation between the companies and marks an early move by Sanofi's new chief executive Belen Garijo to strengthen the company's pipeline.

Sanofi
Sep 20th, 2026
Press Release: Sanofi completes acquisition of Vicebio

Sanofi completes acquisition of Vicebio Paris, December 4, 2025. Sanofi announces the completion of its acquisition of Vicebio Ltd (“Vicebio”). This acquisition brings an early-stage combination...

Sanofi
Sep 20th, 2026
Press Release: Sanofi completes acquisition of Blueprint Medicines

Sanofi completes acquisition of Blueprint Medicines Paris, July 18, 2025. Sanofi today announces the completion of its acquisition of Blueprint Medicines Corporation (Blueprint), adding to its...

Sanofi
Sep 20th, 2026
Press Release: Sanofi completes the acquisition of Dynavax

Sanofi completes the acquisition of Dynavax Paris, February 10, 2026. Sanofi today announced that it has completed the acquisition of Dynavax Technologies Corporation (Dynavax). The acquisition...